Huakang Biomedical Holdings Co (HKSE:08622) Receivables Turnover : 0.00 (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Huakang Biomedical Holdings Co Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Huakang Biomedical Holdings Co's Revenue for the three months ended in Jun. 2024 was HK$0.00 Mil. Huakang Biomedical Holdings Co's average Accounts Receivable for the three months ended in Jun. 2024 was HK$10.48 Mil.

Huakang Biomedical Holdings Co Receivables Turnover Historical Data

The historical data trend for Huakang Biomedical Holdings Co's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huakang Biomedical Holdings Co Receivables Turnover Chart

Huakang Biomedical Holdings Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Receivables Turnover

Get a 7-Day Free Trial

2.42

2.32

2.81

2.56

2.55

Huakang Biomedical Holdings Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24
Receivables Turnover	Get a 7-Day Free Trial															0.62	0.54	0.59	0.71	-

Competitive Comparison of Huakang Biomedical Holdings Co's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Huakang Biomedical Holdings Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Huakang Biomedical Holdings Co's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Huakang Biomedical Holdings Co's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Huakang Biomedical Holdings Co's Receivables Turnover falls into.

Huakang Biomedical Holdings Co Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Huakang Biomedical Holdings Co's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

	Receivables Turnover (A: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2023 )	/ (	(Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )
=	26.939	/ (	(10.575	+	10.591)	/	2 )
=	26.939	/	10.583
=	2.55

Huakang Biomedical Holdings Co's Receivables Turnover for the quarter that ended in Jun. 2024 is calculated as

	Receivables Turnover (Q: Jun. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Jun. 2024 )	/ (	(Accounts Receivable (Q: Dec. 2023 )	+	Accounts Receivable (Q: Jun. 2024 ))	/	count )
=	0	/ (	(10.591	+	10.376)	/	2 )
=	0	/	10.4835
=	N/A

Huakang Biomedical Holdings Co (HKSE:08622) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Huakang Biomedical Holdings Co Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Huakang Biomedical Holdings Co's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Huakang Biomedical Holdings Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huakang Biomedical Holdings Co Ltd (HKSE:08622) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.16 Yinkui Road, 1-3 floor, Building D, Shenzhen Junxuan, Kui Xin Community, Kui Chong Office, Dapeng New District, Shenzhen, CHN

Website

http://www.szhuakang.com

Huakang Biomedical Holdings Co Ltd is engaged in the research, development, manufacture, marketing, and sale of in-vitro diagnostic reagents and auxiliary reproductive supplies and equipment in China. Its products include Male fertility IVD reagents; Parasite antibody detection reagents; EBV antibody detection reagents; and Auxiliary reproductive supplies and equipment. The group has also diversified its business to vitamins and supplements products for the markets in the PRC, Hong Kong, and overseas.

Executives

Arena Investment Management (singapore) Pte Ltd	2102 Investment manager
Arena Investors, Lp	2102 Investment manager
Arena Sg Spv I, Llc	2201 Interest of corporation controlled by you
Tgga, Llc	2106 Person having a security interest in shares
Lau Lai Yee	2201 Interest of corporation controlled by you
Kokusai Resources Company Limited	2101 Beneficial owner
Zhang Shuguang	2101 Beneficial owner
Crystal Grant Limited	2101 Beneficial owner
Chang Yim Yang	2401 A concert party to an agreement to buy shares
Ever Charming Inc.	2101 Beneficial owner
Wealthy Pride Investment Limited	2101 Beneficial owner

Huakang Biomedical Holdings Co Headlines

No Headlines